Jeff Balser, vice chancellor for health affairs and dean of the School of Medicine, announced Wednesday that workforce reduction efforts announced in September at Vanderbilt University Medical Center are completed.

Biomedical and chemical engineers at Vanderbilt University, working with a pathologist, have constructed a sponge-like, biodegradable tissue “scaffold” that releases an enzyme-blocking molecule to indirectly activate endogenous pathways and enhance tissue regeneration and wound healing.

“The downsizing effort is over.” With those words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, announced Wednesday that workforce reduction efforts announced in September at Vanderbilt University Medical Center are completed.

Vanderbilt University’s contributions to the field of diabetes — past and present — were celebrated recently during the annual Diabetes Day at the Vanderbilt Student Life Center.

Jennifer Puck, M.D., an expert on human primary immunodeficiencies at the University of California, San Francisco, will deliver the next Flexner Discovery Lecture on Thursday, Dec. 12.

Vanderbilt University’s Danny Winder, Ph.D., professor of Molecular Physiology and Biophysics, is among 15 scientists nationwide to receive NARSAD Distinguished Investigator Grants this fall for their “cutting-edge” research.